BetterLife Pharma (BETRF) Receivables (2014 - 2026)
BetterLife Pharma (BETRF) posted quarterly Receivables of $5817.1 for Q2 2026, up 0.92% year-over-year from $5763.8 in Q2 2025, and up 182.66% quarter-over-quarter from $2057.9 in Q1 2026.
BetterLife Pharma (BETRF) Receivables (2014 - 2026) Analysis & Trends
BetterLife Pharma's Receivables history runs 11 years deep, the most recent figure standing at $5817.1 for Q2 2026.
- In Q2 2026, Receivables rose 0.92% year-over-year to $5817.1; the TTM figure through Apr 2026 stood at $5817.1 (up 0.92% YoY), while the FY2026 annual figure was $2057.9, down 74.91% from the prior year.
- Receivables for Q2 2026 stood at $5817.1, up from $2057.9 in the prior quarter.
- The five-year high for Receivables was $256771.0 in Q1 2022, with the low at $2057.9 in Q1 2026.
- The 5-year median for Receivables is $12749.0 (2023), against an average of $27587.4.
- The sharpest annual moves came in 2023 and 2024: Receivables slumped 95.03% in 2023, then surged 129.4% in 2024.
- BetterLife Pharma's Receivables stood at $24052.0 in 2022, then sank by 60.68% to $9457.6 in 2023, then sank by 43.14% to $5377.9 in 2024, then climbed by 24.47% to $6694.2 in 2025, then dropped by 13.1% to $5817.1 in 2026.
- Business Quant data shows BETRF's Receivables at $5817.1 in Q2 2026, $2057.9 in Q1 2026, and $6694.2 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.22 Bn | 132.37 Bn | 2.84 Bn | 2.13 Bn |
| 2 | Regeneron Pharmaceuticals | 86.29 Bn | 78.30 Bn | 3.93 Bn | 6.57 Bn |
| 3 | Argenx Se | 65.17 Bn | 59.98 Bn | 1.37 Bn | 1.93 Bn |
| 4 | Moderna | 61.38 Bn | 56.24 Bn | 52.00 Mn | 160.00 Mn |
| 5 | BeOne Medicines | 42.18 Bn | 37.09 Bn | 1.53 Bn | 1.06 Bn |
| 6 | Alnylam Pharmaceuticals | 30.99 Bn | 27.68 Bn | 992.69 Mn | 912.74 Mn |
| 7 | BioNTech SE | 28.45 Bn | 10.05 Bn | 668.28 Mn | 1.09 Bn |
| 8 | Insmed | 27.47 Bn | 26.31 Bn | 358.27 Mn | 215.33 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | BetterLife Pharma | 40.15 Mn | 42.53 Mn | - | 5,817.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2026 | 5,817.08 |
| Jan 31, 2026 | 2,057.95 |
| Jul 31, 2025 | 6,694.17 |
| Apr 30, 2025 | 5,763.78 |
| Jan 31, 2025 | 8,202.35 |
| Oct 31, 2024 | 5,377.93 |
| Jul 31, 2024 | 18,248.31 |
| Apr 30, 2024 | 16,474.73 |
| Jan 31, 2024 | 29,245.63 |
| Oct 31, 2023 | 9,457.62 |
| Jul 31, 2023 | 8,929.01 |
| Apr 30, 2023 | 26,486.78 |
| Jan 31, 2023 | 12,749.02 |
| Oct 31, 2022 | 24,052.00 |
| Jul 31, 2022 | 17,097.04 |
| Apr 30, 2022 | 15,562.13 |
| Jan 31, 2022 | 256,771.00 |
| Oct 31, 2021 | 62,815.72 |
| Jul 31, 2021 | 81,712.50 |
| Apr 30, 2021 | 103,691.57 |